Citadel Advisors - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$23,665
+430.4%
49,066
+127.6%
0.00%
Q1 2023$4,462
-97.4%
21,555
-93.3%
0.00%
Q4 2022$169,811
+76.9%
321,916
+68.7%
0.00%
Q3 2022$96,000
-81.1%
190,797
-33.0%
0.00%
Q2 2022$507,000
+496.5%
284,580
+120.9%
0.00%
Q1 2022$85,000
-70.5%
128,800
-59.0%
0.00%
Q4 2021$288,000
-83.0%
314,416
-23.6%
0.00%
Q3 2021$1,690,000
+622.2%
411,309
+660.3%
0.00%
Q2 2021$234,000
-22.5%
54,100
-9.7%
0.00%
Q1 2021$302,000
-39.6%
59,900
-24.4%
0.00%
Q4 2020$500,000
+275.9%
79,220
+156.2%
0.00%
Q3 2020$133,000
-95.2%
30,921
-93.4%
0.00%
-100.0%
Q2 2020$2,750,000
-9.4%
468,262
-32.6%
0.00%0.0%
Q1 2020$3,035,000
+15.0%
694,642
+79.2%
0.00%0.0%
Q4 2019$2,640,000
+81.8%
387,682
+31.1%
0.00%0.0%
Q3 2019$1,452,000
+204.4%
295,815
+356.8%
0.00%
Q2 2019$477,000
-3.8%
64,764
+6.1%
0.00%
Q1 2019$496,000
-15.6%
61,065
-18.1%
0.00%
Q4 2018$588,000
-33.9%
74,531
-9.8%
0.00%
Q3 2018$890,000
-13.3%
82,612
-6.1%
0.00%
Q2 2018$1,027,000
+229.2%
88,019
+627.4%
0.00%
Q1 2018$312,00012,1000.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders